MedPath

Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study

Completed
Conditions
Oesophageal Cancer
Registration Number
NCT04440124
Lead Sponsor
University Hospital Birmingham NHS Foundation Trust
Brief Summary

The purpose of this study was to assess the predictive value of the incremental shuttle walk test on rates of hospital acquired pneumonia for patients undergoing oesophagectomy.

Detailed Description

Field tests to objectively measure functional capacity are becoming of greater importance when looking to assess an individual's fitness for surgery. One such field test is the incremental shuttle walk test (ISWT). An externally paced, maximal excursion test, the ISWT is a simple and easily reproducible test that is widely used within cardiac and pulmonary populations and shown to correlate well with Vo2 mas on a cardiopulmonary exercise test. Previous studies looking at the benefit of the ISWT in predicting post-operative outcomes within the oesophagastric population have demonstrated that walking less than 350 meters has been associated with significantly higher rates of mortality at 30 days and 3 years. No correlation between ISWT and postoperative respiratory complications in this surgical population has been previously reported.

This study aims to assess whether walking \<350 meters on an ISWT predicts the development of hospital acquired pneumonias following an elective oesophagectomy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
121
Inclusion Criteria
  • Consecutive patients with a diagnosis of oesophagogastric cancer listed for an elective oesophagectomy at a large UK tertiary hospital
Exclusion Criteria
  • Patients who were unable to complete the walking test
  • patients deemed not fit for surgery
  • patients with a significant neurological event peri or post operatively

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hospital acquired pneumoniaduring hospital stay, on average 14 days

The incidence of hospital acquired pneumonia as defined by the US centres for Disease Control

Secondary Outcome Measures
NameTimeMethod
90 day Mortality90 days following date of surgery

Mortality rates 90 days post operatively

30 day Mortality30 days after date of surgery

Mortality rates 30 days post operatively

Trial Locations

Locations (1)

UHB NHS Foundation Trust

🇬🇧

Birmingham, United Kingdom

UHB NHS Foundation Trust
🇬🇧Birmingham, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.